日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers

EZH2 抑制剂 Tulmimetostat 的全面靶向作用可靶向治疗 ARID1A 突变癌症

Patricia J Keller #, Elizabeth J Adams #, Rentian Wu #, Alexandre Côté, Shilpi Arora, Nico Cantone, Rosana Meyer, Jennifer A Mertz, Victor Gehling, Jike Cui, Jacob I Stuckey, Avinash Khanna, Feng Zhao, Zehua Chen, Ziyang Yu, Richard T Cummings, Mohammed Taimi, Nehal J Lakhani, Drew Rasco, Martin Gut

Immunohistochemical expression of bcl-2; an apoptosis regulatory protein in squamous cell carcinoma of oropharynx: A diagnostic cross-sectional study

口咽鳞状细胞癌中凋亡调节蛋白bcl-2的免疫组织化学表达:一项诊断性横断面研究

Bhutani, Namita; Poswal, Pooja; Moga, Shilpi; Arora, Sunil

Large Fibrinous Coagulum in the Platelet Bag: A Hint Towards Bacterial Contamination

血小板袋内出现大量纤维凝块:提示细菌污染

Gupta, Anubhav; Chaudhary, Kiran; Pokhrel, Anupa; Sachdeva, Prerna; Varshney, Shilpi; Arora, Harkiran; Asati, Swati

Activity Wise Unit Cost of Blood Components in a Tertiary Care Hospital Blood Bank for the Year 2018

2018年三级医院血库血液成分的单位成本(按活动划分)

Pokhrel, Anupa; Chaudhary, Kiran; Sachdeva, Prerna; Gupta, Anubhav; Varshney, Shilpi; Arora, Harkiran

Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes

组蛋白赖氨酸去甲基化酶 KDM1A 的药理抑制可抑制多种急性髓系白血病亚型的生长

John P McGrath, Kaylyn E Williamson, Srividya Balasubramanian, Shobu Odate, Shilpi Arora, Charlie Hatton, Thomas M Edwards, Thomas O'Brien, Steven Magnuson, David Stokoe, Danette L Daniels, Barbara M Bryant, Patrick Trojer

RNAi screening of the kinome with cytarabine in leukemias

利用阿糖胞苷对白血病中的激酶组进行 RNAi 筛选

Raoul Tibes, James M Bogenberger, Leena Chaudhuri, R Tanner Hagelstrom, Donald Chow, Megan E Buechel, Irma M Gonzales, Tim Demuth, James Slack, Ruben A Mesa, Esteban Braggio, Hongwei H Yin, Shilpi Arora, David O Azorsa

Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies

Foxo3a 通过转录调控细胞周期蛋白 A1 来驱动未分化甲状腺癌的增殖:影响当前治疗策略的范式转变

Laura A Marlow, Christina A von Roemeling, Simon J Cooper, Yilin Zhang, Stephen D Rohl, Shilpi Arora, Irma M Gonzales, David O Azorsa, Honey V Reddi, Han W Tun, Heike R Döppler, Peter Storz, Robert C Smallridge, John A Copland

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma

转移性嗅神经母细胞瘤的配对肿瘤和正常组织全基因组测序

Glen J Weiss ,Winnie S Liang, Tyler Izatt, Shilpi Arora, Irene Cherni, Robert N Raju, Galen Hostetter, Ahmet Kurdoglu, Alexis Christoforides, Shripad Sinari, Angela S Baker, Raghu Metpally, Waibhav D Tembe, Lori Phillips, Daniel D Von Hoff, David W Craig, John D Carpten

Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target

四种新型甲状腺未分化癌细胞系的详细分子指纹分析及其用于验证 RhoB 作为分子治疗靶点的应用

Laura A Marlow, Jaclyn D'Innocenzi, Yilin Zhang, Stephen D Rohl, Simon J Cooper, Thomas Sebo, Clive Grant, Bryan McIver, Jan L Kasperbauer, J Trad Wadsworth, John D Casler, Pamela W Kennedy, W Edward Highsmith, Orlo Clark, Dragana Milosevic, Brian Netzel, Kendall Cradic, Shilpi Arora, Christian Beau

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

合成致死 RNAi 筛选确定胰腺癌吉西他滨治疗的敏感靶点

David O Azorsa, Irma M Gonzales, Gargi D Basu, Ashish Choudhary, Shilpi Arora, Kristen M Bisanz, Jeffrey A Kiefer, Meredith C Henderson, Jeffrey M Trent, Daniel D Von Hoff, Spyro Mousses